Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tubal Patency and Hormonal Contraceptives Pilot Study
NCT02146248Completed
- Start
- May 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of medroxyprogesterone acetate in contraception. Primary endpoint: Number of Participants With Bilateral Tubal Patency as Assessed by HSG-follicular. Started May 2014; status: completed.
02
Drugs
medroxyprogesterone acetate
03
Conditions
contraception
Beyond the preview
Go deeper on NCT02146248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02146248.